أعرض في EDS

Corrigendum: Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study [Front Immunol, 8, (2017), (386)] doi: 10.3389/fimmu.2017.00386

التفاصيل البيبلوغرافية
العنوان: Corrigendum: Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study [Front Immunol, 8, (2017), (386)] doi: 10.3389/fimmu.2017.00386
المؤلفون: Queirolo, P., Dozin, B., Morabito, A., Banelli, B., Piccioli, P., Fava, C., Leo, C., Carosio, R., Laurent, S., Fontana, V., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Battaglia, A., Ascierto, P. A., Capone, M., Simeone, E., De Galitiis, F., Pagani, E., Cappellini, G. C. A., Marchetti, P., Guida, M., Tommasi, S., Mandala, M., Merelli, B., Quaglino, P., Fava, P., Guidoboni, M., Romani, M., Spagnolo, F., Pistillo, M. P.
سنة النشر: 2018
مصطلحات موضوعية: Best overall response, CTLA-4 variants, Ipilimumab, Melanoma, Overall survival, Predictive/prognostic factor
اللغة: English
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______970::a80a4da44e455349e591c4e567ded3d6
https://hdl.handle.net/2318/1890637
حقوق: CLOSED
رقم الأكسشن: edsair.od.......970..a80a4da44e455349e591c4e567ded3d6
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.